Chris Dowd, ConnectiveRx

Amid intensified competition—and evolving IRA and PBM dynamics—leaders in the access space must now adopt a strategist mindset.

Conversation with chief tech expert explores AI’s rise in the support space—and separating the substance from the noise.

Doubling down on patient access and support fundamentals will win out over Washington’s next move.

The key strategies for reducing or eliminating post-prescription abandonment.

From matrix programs to anti-abandonment strategies, predictions for a new era.

What does the legislation mean for patient access leaders, pharma brand managers, and patient service owners? Industry experts weigh in.

The biggest areas of adjustment in patient support brought on by changes in consumer and physician behavior